相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Organic Anion Transporting Polypeptides (OATPs): Regulation of Expression and Function
Martin Svoboda et al.
CURRENT DRUG METABOLISM (2011)
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
David G. Bailey
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Grapefruit Juice Greatly Reduces the Plasma Concentrations of the OATP2B1 and CYP3A4 Substrate Aliskiren
T. Tapaninen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Cyclosporine A, but Not Tacrolimus, Shows Relevant Inhibition of Organic Anion-Transporting Protein 1B1-Mediated Transport of Atorvastatin
Rune Amundsen et al.
DRUG METABOLISM AND DISPOSITION (2010)
Herb-drug pharmacokinetic interactions reviewed
Clemence Tarirai et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Therapeutic implications of renal anionic drug transporters
Rosalinde Masereeuw et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Drug interactions evaluation: An integrated part of risk assessment of therapeutics
Lei Zhang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters
Olena Kis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1
P. Annaert et al.
XENOBIOTICA (2010)
Impact of OATP transporters on pharmacokinetics
A. Kalliokoski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Involvement of Influx and Efflux Transport Systems in Gastrointestinal Absorption of Celiprolol
Yukio Kato et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Scientific and Regulatory Perspectives on Metabolizing Enzyme-Transporter Interplay and Its Role in Drug Interactions: Challenges in Predicting Drug Interactions
Lei Zhang et al.
MOLECULAR PHARMACEUTICS (2009)
Interaction of imatinib with human organic ion carriers
Shuiying Hu et al.
CLINICAL CANCER RESEARCH (2008)
Potential of pharmacokinetic profiling for detecting herbal interactions with drugs
Veronika Butterweck et al.
CLINICAL PHARMACOKINETICS (2008)
The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)
Gergely Szakacs et al.
DRUG DISCOVERY TODAY (2008)
The solute carrier (SLC) complement of the human genome: Phylogenetic classification reveals four major families
Robert Fredriksson et al.
FEBS LETTERS (2008)
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
Shiew-Mei Huang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
S. -F. Zhou
XENOBIOTICA (2008)
Physiology, structure, and regulation of the cloned organic anion transporters
C. Srimaroeng et al.
XENOBIOTICA (2008)
P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution
Naveed Shaik et al.
DRUG METABOLISM AND DISPOSITION (2007)
Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: Implications for predicting clinical drug interactions
Vaishali Dixit et al.
DRUG METABOLISM AND DISPOSITION (2007)
Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines
Constanze Hilgendorf et al.
DRUG METABOLISM AND DISPOSITION (2007)
Role of OATP transporters in the disposition of drugs
Mikko Niemi
PHARMACOGENOMICS (2007)
Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol
U. I. Schwarz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice
D. G. Bailey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Organic anion transporters of the SLC22 family: Biopharmaceutical, physiological, and pathological roles
Ahsan N. Rizwan et al.
PHARMACEUTICAL RESEARCH (2007)
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
Pertti J. Neuvonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition
Ute I. Schwarz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants
Ilaria Badagnani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Drug-drug interaction between pitavastatin and various drugs via OATP1B1
Masaru Hirano et al.
DRUG METABOLISM AND DISPOSITION (2006)
Flavonoid-drug interactions: Effects of flavonoids on ABC transporters
ME Morris et al.
LIFE SCIENCES (2006)
MDR- and CYMA4-mediated drug-herbal interactions
D Pal et al.
LIFE SCIENCES (2006)
Drug-associated renal dysfunction and injury
D Choudhury et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2006)
P-glycoprotein recognition of substrates and circumvention through rational drug design
Thomas J. Raub
MOLECULAR PHARMACEUTICS (2006)
A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters
H Tahara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Cyclosporine markedly raises the plasma concentrations of repaglinide
LI Kajosaari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Effects of orange juice on the pharmacokinetics of atenolol
JJ Lilja et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Grapefruit juice ingestion significantly reduces talinolol bioavailability
UI Schwarz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: Possible role of organic anion transporting polypeptides
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
CY Wu et al.
PHARMACEUTICAL RESEARCH (2005)
Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide
TB Bidstrup et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine
S Khamdang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins - Introduction
MA Hediger et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA-reductase inhibitors
M Takeda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine
SG Simonson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers
R Ding et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Herbal modulation of P-glycoprotein
SF Zhou et al.
DRUG METABOLISM REVIEWS (2004)
Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: What have we learned?
SM Huang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin:: Analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil
Y Shitara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
P-glycoprotein: from genomics to mechanism
SV Ambudkar et al.
ONCOGENE (2003)
Gemfibrozil considerably increases the plasma concentrations of rosiglitazone
M Niemi et al.
DIABETOLOGIA (2003)
CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide
TB Bidstrup et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone
RI Fox et al.
RHEUMATOLOGY (2003)
Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient
DH Sweet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol
JJ Lilja et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Transport of cimetidine by flounder and human renal organic anion transporter 1
BC Burckhardt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
The superfamily of organic anion transporting polypeptides
B Hagenbuch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Prevalence of complementary and alternative medicine use: State-specific estimates from the 2001 behavioral risk factor surveillance system
AP Rafferty et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2002)
Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures
J van Gelder et al.
DRUG METABOLISM AND DISPOSITION (2002)
Effect of St John's wort on the pharmacokinetics of fexofenadine
ZQ Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Lack of Bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: A new twist on an old interaction
AL Neuhofel et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Recent patterns of medication use in the ambulatory adult population of the United States - The Slone survey
DW Kaufman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
St John's Wort increases expression of P-glycoprotein: Implications for drug interactions
M Hennessy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Saint John's wort:: An in vitro analysis of P-glycoprotein induction due to extended exposure
MD Perloff et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters
M Takeda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
The effect of rifampin administration on the disposition of fexofenadine
MA Hamman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
The gut as a barrier to drug absorption - Combined role of cytochrome P450 3A and P-glycoprotein
YC Zhang et al.
CLINICAL PHARMACOKINETICS (2001)
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction
K Westphal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials
A Sparber et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2000)
Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P-glycoprotein
K Westphal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology
MA Richardson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A
I Binet et al.
KIDNEY INTERNATIONAL (2000)
分享论文
